MyBlueDots

NASHVILLE, Tenn.–(BUSINESS WIRE)– #biohacking–Next Health debuts in Tennessee with its first Nashville location opening Jan. 20 in The Gulch, offering health optimization and longevity services.

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with Bacillus Calmette-Guérin (BCG) as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The study met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a c

DUBLIN–(BUSINESS WIRE)–The “Medical PET Patent Landscape Report” has been added to ResearchAndMarkets.com’s offering. This report presents an in-depth analysis of the patent landscape for Medical PET, encompassing 1,408 patents filed from 2010 to 2024. The field of Medical PET has witnessed notable growth, with recent years showcasing a surge in innovation aligned with the expanding applications of PET in healthcare. The United States leads in patent registrations, followed by contributions f

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the fourth quarter and full year of 2024 on February 20, 2025, after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time). The link to the live call will be available

CAMBRIDGE, Mass.–(BUSINESS WIRE)–City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced that it has entered into a strategic collaboration with global eye health leader Bausch + Lomb focused on the development of a novel therapy for the treatment of retinal diseases including geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD) that causes irreversible vision loss. Through

DENVER–(BUSINESS WIRE)–Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced key initiatives to support future growth. The Company has secured $75 million in incremental financing, backed by stakeholders across the capital structure, and appointed Chad Shandler as its Chief Transformation Officer. An existing investor, Coli